CRISPR-Cas spacer acquisition is a rare event in human gut microbiome
Cell Genomics · 2025-01 · 5 (1) · 100725
DOI: 10.1016/j.xgen.2024.100725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Genomics, 2025-01. Verfasst von An-Ni Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; School of Biological Sciences, Nanyang Technological…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, CRISPR-Cas Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Broad Institute, Nanyang Technological University.
Abstract (Originalsprache)
Host-parasite relationships drive the evolution of both parties. In microbe-phage dynamics, CRISPR functions as an adaptive defense mechanism, updating immunity via spacer acquisition. Here, we investigated these interactions within the human gut microbiome, uncovering low frequencies of spacer acquisition at an average rate of one spacer every ∼2.9 point mutations using isolates' whole genomes and ∼2.7 years using metagenome time series. We identified a highly prevalent CRISPR array in Bifidobacterium longum spreading via horizontal gene transfer (HGT), with six spacers found in various genomic regions in 15 persons from the United States and Europe. These spacers, targeting two prominent Bifidobacterium phages, comprised 76% of spacer occurrence of all spacers targeting these phages in all B. longum populations. This result suggests that HGT of an entire CRISPR-Cas system introduced three times more spacers than local CRISPR-Cas acquisition in B. longum. Overall, our findings identified key ecological and evolutionary factors in prokaryote adaptive immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore. Electronic address: anni.zhang@ntu.…
- School of Biological Sciences, Nanyang Technological University, Singapore, Singapore; Google, Cambridge, MA, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore, Singapore.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic…
Förderung
- Broad Institute
- Nanyang Technological University
Zitieren
APA
Zhang, A. N., Gaston, J. M., Cárdenas, P., Zhao, S., Gu, X., & Alm, E. J. (2025). CRISPR-Cas spacer acquisition is a rare event in human gut microbiome. Cell Genomics, 5(1), 100725. https://doi.org/10.1016/j.xgen.2024.100725
Vancouver
Zhang AN, Gaston JM, Cárdenas P, Zhao S, Gu X, Alm EJ. CRISPR-Cas spacer acquisition is a rare event in human gut microbiome. Cell Genomics. 2025;5(1):100725. doi:10.1016/j.xgen.2024.100725
BibTeX
@article{Zhang2025,
author = {Zhang, An-Ni and Gaston, Jeffry M and Cárdenas, Pablo and Zhao, Shijie and Gu, Xiaoqiong and Alm, Eric J},
title = {CRISPR-Cas spacer acquisition is a rare event in human gut microbiome},
journal = {Cell Genomics},
year = {2025},
volume = {5},
number = {1},
pages = {100725},
doi = {10.1016/j.xgen.2024.100725}
}
EUVIMED